IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,284 | -7.1% | 367 | 0.0% | 0.00% | – |
| Q2 2023 | $17,521 | +125050.0% | 367 | 0.0% | 0.00% | – |
| Q1 2023 | $14 | +40.0% | 367 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 367 | +4.9% | 0.00% | – |
| Q3 2022 | $11,000 | -56.0% | 350 | -52.4% | 0.00% | – |
| Q2 2022 | $25,000 | -24.2% | 736 | 0.0% | 0.00% | – |
| Q1 2022 | $33,000 | +13.8% | 736 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | -86.6% | 736 | -88.6% | 0.00% | -100.0% |
| Q3 2021 | $217,000 | -19.0% | 6,466 | -29.1% | 0.00% | -50.0% |
| Q2 2021 | $268,000 | +14.0% | 9,125 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $235,000 | +13.0% | 9,125 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $208,000 | +235.5% | 9,125 | +213.7% | 0.00% | – |
| Q3 2020 | $62,000 | – | 2,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |